The increasing popularity of GLP-1 treatments for obesity is reshaping consumer behavior, presenting both risks and opportunities for the FAB industry, says Meaghan Piscitelli, Global Life Sciences Leader, Enterprise Client Group
Santambrogio L, Cuervo AM
Having an on-site surgeon means your protocol can be adjusted in real-time based on your bodys unique response, providing a level of safety and clinical precision that retail or digital weight loss apps cannot match
A study involving 31 women on 5075 mg daily for about five months reported frequent periods (polymenorrhea) as the most common side effect, while other adverse effects were minimal
Researchers utilize this blend to study complex dermatological models, specifically focusing on downregulating pro-inflammatory cytokines (like NF-B) in conditions resembling dermatitis, psoriasis, and compromised skin barriers
Retroviral mediated introduction of the multidrug (MDR-1) cDNA confers Taxol resistance on long-term culture initiating cells (LTCIC) in human marrow transplantation model